Latest News | Lupin Launches Generic HIV-1 Drug in US
Get latest articles and stories on Latest News at LatestLY. Drug maker Lupin on Friday said it has launched Emtricitabine and Tenofovir Disoproxil Fumarate tablets, used in the treatment of HIV-1 infection, in the American market.
New Delhi, Jun 25 (PTI) Drug maker Lupin on Friday said it has launched Emtricitabine and Tenofovir Disoproxil Fumarate tablets, used in the treatment of HIV-1 infection, in the American market.
The Mumbai-based company said it has launched the product in the US market after having received approval from the US Food and Drug Administration (USFDA).
The drug maker's product is the generic version of Gilead Sciences, Inc's Truvada tablets and indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.
It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection.
As per IQVIA MAT March 2021 data, Emtricitabine and Tenofovir disoproxil fumarate tablets had estimated annual sales of USD 2.1 billion in the US.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)